Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07412249 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis

Study acronym: RICSICAS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: 9 to 12v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 10, 2026 to Mar 4, 2026
    • Site details revised
    v3
  3. Secondary endpoints revised (9)
    • Eligibility criteria expanded, about 1 word
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Remote ischemic conditioning (RIC) has emerged as a promising non-invasive strategy to protect the brain, with evidence suggesting its benefit in patients with carotid artery stenting (CAS). However, the long-term benefit and safety of chronic RIC in this population remain unknown. This trial aims to evaluate whether chronic RIC reduces the incidence of major vascular events and improves clinical outcomes in high-risk patients with carotid artery stenosis who received CAS.
Trial Details
NCT Number NCT07412249
Lead Sponsor General Hospital of Shenyang Military Region
Conditions
(from sponsor)		 Carotid Stenosis
Related terms Carotid Stenosis
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov